Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
13 Apr 2021
Historique:
received: 19 10 2020
accepted: 29 03 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 20 11 2021
Statut: epublish

Résumé

Cystic fibrosis is a debilitating, autosomal recessive disease which results in chronic upper and lower airway infection and inflammation. In this study, four adult patients presenting with cystic fibrosis and chronic rhinosinusitis were recruited. Culture and molecular techniques were employed to evaluate changes in microbial profiles, host gene expression and antimicrobial resistance (AMR) in the upper respiratory tract over time. Swab samples from the sinonasal cavity were collected at the time of surgery and at follow-up clinics at regular time intervals for up to 18 months. Nucleic acids were extracted, and DNA amplicon sequencing was applied to describe bacterial and fungal composition. In parallel, RNA was used to evaluate the expression of 17 AMR genes and two inflammatory markers (interleukins 6 and 8) using custom qPCR array cards. Molecular results were compared with routine sinus and sputum culture reports within each patient. Bacterial amplicon sequencing and swab culture reports from the sinonasal cavity were mostly congruent and relatively stable for each patient across time. The predominant species detected in patients P02 and P04 were Pseudomonas aeruginosa, Staphylococcus aureus in patient P03, and a mixture of Enterobacter and S. aureus in patient P01. Fungal profiles were variable and less subject specific than bacterial communities. Increased expressions of interleukins 6 and 8 were observed in all patients throughout the sampling period compared with other measured genes. The most prevalent AMR gene detected was ampC. However, the prevalence of AMR gene expression was low in all patient samples across varying time-points. We observed a surprising degree of stability of sinonasal microbial composition, and inflammatory and AMR gene expression across all patients post sinus surgery.

Sections du résumé

BACKGROUND BACKGROUND
Cystic fibrosis is a debilitating, autosomal recessive disease which results in chronic upper and lower airway infection and inflammation. In this study, four adult patients presenting with cystic fibrosis and chronic rhinosinusitis were recruited. Culture and molecular techniques were employed to evaluate changes in microbial profiles, host gene expression and antimicrobial resistance (AMR) in the upper respiratory tract over time.
METHODS METHODS
Swab samples from the sinonasal cavity were collected at the time of surgery and at follow-up clinics at regular time intervals for up to 18 months. Nucleic acids were extracted, and DNA amplicon sequencing was applied to describe bacterial and fungal composition. In parallel, RNA was used to evaluate the expression of 17 AMR genes and two inflammatory markers (interleukins 6 and 8) using custom qPCR array cards. Molecular results were compared with routine sinus and sputum culture reports within each patient.
RESULTS RESULTS
Bacterial amplicon sequencing and swab culture reports from the sinonasal cavity were mostly congruent and relatively stable for each patient across time. The predominant species detected in patients P02 and P04 were Pseudomonas aeruginosa, Staphylococcus aureus in patient P03, and a mixture of Enterobacter and S. aureus in patient P01. Fungal profiles were variable and less subject specific than bacterial communities. Increased expressions of interleukins 6 and 8 were observed in all patients throughout the sampling period compared with other measured genes. The most prevalent AMR gene detected was ampC. However, the prevalence of AMR gene expression was low in all patient samples across varying time-points.
CONCLUSIONS CONCLUSIONS
We observed a surprising degree of stability of sinonasal microbial composition, and inflammatory and AMR gene expression across all patients post sinus surgery.

Identifiants

pubmed: 33849523
doi: 10.1186/s12931-021-01697-w
pii: 10.1186/s12931-021-01697-w
pmc: PMC8045235
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106

Subventions

Organisme : Garnett Passe and Rodney Williams Memorial Foundation
ID : 37016403

Références

Laryngoscope. 2019 Mar;129(3):544-550
pubmed: 30284279
J Cyst Fibros. 2013 Mar;12(2):154-64
pubmed: 22951208
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14
pubmed: 22451929
Med Sci (Basel). 2019 Feb 22;7(2):
pubmed: 30813317
Am J Rhinol Allergy. 2019 Jul;33(4):354-358
pubmed: 30781973
J Allergy Clin Immunol. 1999 Jul;104(1):72-8
pubmed: 10400842
J Clin Microbiol. 2014 Feb;52(2):425-37
pubmed: 24478471
Nucleic Acids Res. 2003 Dec 15;31(24):e154
pubmed: 14654707
Xenobiotica. 2020 Dec;50(12):1443-1450
pubmed: 32840412
Sci Rep. 2019 Nov 22;9(1):17416
pubmed: 31758066
Nat Commun. 2014 Sep 02;5:4780
pubmed: 25179232
J Cyst Fibros. 2006 May;5(2):113-9
pubmed: 16481223
J Cyst Fibros. 2013 Dec;12(6):729-36
pubmed: 23478131
Front Microbiol. 2019 Jan 11;9:3242
pubmed: 30692969
Nucleic Acids Res. 2014 Jan;42(Database issue):D643-8
pubmed: 24293649
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
Pediatr Clin North Am. 2016 Aug;63(4):567-84
pubmed: 27469176
J Clin Microbiol. 2017 Apr;55(4):1122-1130
pubmed: 28100601
Clin Med Insights Circ Respir Pulm Med. 2019 May 22;13:1179548419849939
pubmed: 31205434
Heliyon. 2018 Sep 17;4(9):e00795
pubmed: 30238064
Rhinology. 2012 Mar;50(1):1-12
pubmed: 22469599
Am J Rhinol. 2005 Jan-Feb;19(1):47-51
pubmed: 15794074
Otolaryngol Head Neck Surg. 2018 Feb;158(2):381-385
pubmed: 29182491
Int Forum Allergy Rhinol. 2019 Jul;9(7):759-765
pubmed: 31162888
Int Forum Allergy Rhinol. 2017 Mar;7(3):230-239
pubmed: 27879060
Eur Respir J. 2017 Nov 16;50(5):
pubmed: 29146601
Front Pediatr. 2017 Mar 03;5:44
pubmed: 28316969
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439
Microbiome. 2013 Nov 01;1(1):27
pubmed: 24451123
J Cyst Fibros. 2018 Mar;17(2):204-212
pubmed: 28826586
PLoS One. 2017 Mar 2;12(3):e0172811
pubmed: 28253277
Int Forum Allergy Rhinol. 2017 Jan;7(1):7-15
pubmed: 27641913
Microbiome. 2020 Apr 2;8(1):45
pubmed: 32238195
Front Microbiol. 2015 Mar 02;9:134
pubmed: 25784909
Bioinformatics. 2015 Nov 1;31(21):3476-82
pubmed: 26139637
Sci Rep. 2019 Nov 12;9(1):16564
pubmed: 31719577
Nature. 2000 Oct 12;407(6805):762-4
pubmed: 11048725
Am J Respir Crit Care Med. 1996 Jan;153(1):362-8
pubmed: 8542144
J Cyst Fibros. 2017 Jan;16(1):107-115
pubmed: 27296563
Mol Ecol. 2013 Nov;22(21):5271-7
pubmed: 24112409
Int Forum Allergy Rhinol. 2019 Dec;9(12):1462-1469
pubmed: 31483577
Thorax. 2009 Jun;64(6):535-40
pubmed: 19282318

Auteurs

Brett Wagner Mackenzie (B)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand. bc.wagner@auckland.ac.nz.

Camila Dassi (C)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.

Anitha Vivekanandan (A)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.

Melissa Zoing (M)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.

Richard G Douglas (RG)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.

Kristi Biswas (K)

Department of Surgery, The University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH